Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ): A Case Report
Journal of the Peripheral Nervous System · 2025-03 · 30 (1)
DOI: 10.1111/jns.70010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 02.03.2025. Verfasst von Edoardo Dalmato Schilke und 12 weiteren Autor:innen. Beteiligte Einrichtung: PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Antibodies, Monoclonal, Humanized, Immunologic Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare immune‐mediated disorder; about 20%–30% of patients do not adequately respond to first‐line treatments (immunoglobulins, therapeutic plasmapheresis, and corticosteroids) posing diagnostic and therapeutic challenges. Case Report We report the case of a 58‐year‐old man diagnosed with CIDP. During follow‐up, he progressively became refractory to all first‐line treatments. Therefore, 20 months after the diagnosis, an add‐on therapy with Rituximab was tried. Despite previous works supporting the use of Rituximab in refractory CIDP, in our case, the patient experienced relapses and progressive increases in disability. After the exclusion of potential CIDP mimics and considering the histological findings that showed complement activation, we opted for an innovative therapeutic approach with Eculizumab that granted a significant clinical and neurophysiological benefit that persists after 7 months of follow‐up. Interpretation CIDP pathogenesis is characterized by a complex interplay of different immunopathological mechanisms, and the complement system may play a major role. The present case supports the role of complement‐dependent toxicity in CIDP and suggests that complement‐targeted therapies may represent a well‐tolerated and effective alternative for CIDP treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
- Neurology Clinic, Foundation IRCCS San Gerardo Dei Tintori, Monza, Italy.
- Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Rehabilitation Medicine, Valduce Hospital - Villa-Beretta, Costa Masnaga, Italy.
- School of Medicine and Surgery and Milan Centre for Neuroscience (NeuroMI), University of Milano-Bicocca, Milan, Italy.
- Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
ORCID-Profile: Edoardo Dalmato Schilke, Guido Cavaletti
Zitieren
APA
Schilke, E. D., Cereda, D., Fusco, M. L., Stanzani, L., Marzorati, L., Ripolone, M., Bertolasi, L., Frigo, M., Molteni, F., Farina, N., Ferrarese, C., Cavaletti, G., & Balducci, C. (2025). Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ): A Case Report. Journal of the Peripheral Nervous System, 30(1). https://doi.org/10.1111/jns.70010
Vancouver
Schilke ED, Cereda D, Fusco ML, Stanzani L, Marzorati L, Ripolone M, et al. Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ): A Case Report. Journal of the Peripheral Nervous System. 2025;30(1). doi:10.1111/jns.70010
BibTeX
@article{Schilke2025,
author = {Schilke, Edoardo Dalmato and Cereda, Diletta and Fusco, Maria Letizia and Stanzani, Lorenzo and Marzorati, Laura and Ripolone, Michela and Bertolasi, Letizia and Frigo, Maura and Molteni, Franco and Farina, Nico and Ferrarese, Carlo and Cavaletti, Guido and Balducci, Claudia},
title = {Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ): A Case Report},
journal = {Journal of the Peripheral Nervous System},
year = {2025},
volume = {30},
number = {1},
doi = {10.1111/jns.70010}
}
EUVIMED